Plasma-Lyte 148 (ph 7.4) Solution for Infusion (500ml) Malta - English - Medicines Authority

plasma-lyte 148 (ph 7.4) solution for infusion (500ml)

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - sodium chloride, potassium chloride, magnesium chloride, hexahydrate, sodium acetate, trihydrate, sodium gluconate - solution for infusion - sodium chloride 5.26 g/l potassium chloride 0.37 g/l magnesium chloride hexahydrate 0.30 g/l sodium acetate trihydrate 3.68 g/l sodium gluconate 5.02 g/l - blood substitutes and perfusion solutions

Plasma-Lyte 148 (ph 7.4) Solution for Infusion (1000ml) Malta - English - Medicines Authority

plasma-lyte 148 (ph 7.4) solution for infusion (1000ml)

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - sodium chloride, potassium chloride, magnesium chloride, hexahydrate, sodium acetate, trihydrate, sodium gluconate - solution for infusion - potassium chloride 0.37 g/l magnesium chloride hexahydrate 0.30 g/l sodium acetate trihydrate 3.68 g/l sodium gluconate 5.02 g/l sodium chloride 5.26 g/l - blood substitutes and perfusion solutions

GLIVEC 400 MG Israel - English - Ministry of Health

glivec 400 mg

novartis israel ltd - imatinib as mesylate - film coated tablets - imatinib as mesylate 400 mg - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) who have the fip1l1- pdgfralfa fusion kinase (mutational analysis or fish demonstration for chic2 allele deletion) and for patients with hes and/or cel who are fip1l1-pdgfr alfa fusion kinase negative . adult patients with aggressive systemic mastocytosis (asm) without the d816v c-kit mutation . adjuvant treatment of adult patients following complete gross resection of kit (cd117) positive gist.

FEM PH- acetic acid and oxyquinoline sulfate jelly United States - English - NLM (National Library of Medicine)

fem ph- acetic acid and oxyquinoline sulfate jelly

pharmics, inc. - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p), oxyquinoline sulfate (unii: 61vug75y3p) (oxyquinoline - unii:5utx5635hp) - acetic acid 0.009 g in 1 g - fem ph is indicated as adjunctive therapy in those cases where restoration and maintenance of vaginal acidity is desirable. none known.

KOACT 312.50 (Co-Amoxiclav for Oral Suspension 250-62.50mg5ml). Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

koact 312.50 (co-amoxiclav for oral suspension 250-62.50mg5ml).

unimed sdn bhd - potassium clavulanate ph. eur.; amoxicillin trihydrate ph. eur. -

Phoxilium 1.2 mmol/l phosphate Solution for haemodialysis/haemofiltration Ireland - English - HPRA (Health Products Regulatory Authority)

phoxilium 1.2 mmol/l phosphate solution for haemodialysis/haemofiltration

gambro lundia ab - calcium chloride dihydrate; magnesium chloride hexahydrate; sodium chloride ph.eur.; sodium hydrogen carbonate; potassium chloride; disodium phosphate dihydrate - solution for haemodialysis/haemofiltration - 1.2 mmol/l - hemofiltrates

Scemblix European Union - English - EMA (European Medicines Agency)

scemblix

novartis europharm limited - asciminib hydrochloride - leukemia, myelogenous, chronic, bcr-abl positive - antineoplastic agents - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.1).

Prismasol 2 mmol/l Potassium solution for haemodialysis/haemofiltration Ireland - English - HPRA (Health Products Regulatory Authority)

prismasol 2 mmol/l potassium solution for haemodialysis/haemofiltration

baxter holding b.v. - glucose (as monohydrate); magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium chloride ph.eur.; potassium chloride; sodium hydrogen carbonate; calcium; magnesium; sodium; lactate; hydrogen carbonate; chloride; potassium; glucose - solution for haemodialysis/haemofiltration - 2 millimole(s)/litre - hemofiltrates

IRBEJUB H (Irbesartan and Hydrochlorothiazide Tablets 150 mg+12.5 mg) Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

irbejub h (irbesartan and hydrochlorothiazide tablets 150 mg+12.5 mg)

pharmaniaga marketing sdn bhd - irbesartan; hydrochlorothiazide* ph. eur -

IRBEJUB H (Irbesartan and Hydrochlorothiazide Tablets 300 mg+12.5 mg) Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

irbejub h (irbesartan and hydrochlorothiazide tablets 300 mg+12.5 mg)

pharmaniaga marketing sdn bhd - irbesartan; hydrochlorothiazide* ph. eur -